ACCENTURE ($ACN) posted quarterly earnings results for Q2 2026 on Thursday, March 19th. The company reported earnings of $2.93 per share, beating estimates of $2.87 by $0.06. The company also reported revenue of $18,044,070,000, beating estimates of $18,006,468,233 by $37,601,767.
You can see Quiver Quantitative's $ACN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ACCENTURE Insider Trading Activity
ACCENTURE insiders have traded $ACN stock on the open market 87 times in the past 6 months. Of those trades, 0 have been purchases and 87 have been sales.
Here’s a breakdown of recent trading of $ACN stock by insiders over the last 6 months:
- JULIE SPELLMAN SWEET (Chair and CEO) has made 0 purchases and 35 sales selling 37,168 shares for an estimated $9,268,631.
- MANISH SHARMA (Chief Strategy & Services Ofcr) has made 0 purchases and 9 sales selling 9,731 shares for an estimated $2,536,952.
- JOHN F WALSH (CEO-The Americas) has made 0 purchases and 9 sales selling 4,000 shares for an estimated $1,105,033.
- MELISSA A BURGUM (Chief Accounting Officer) has made 0 purchases and 6 sales selling 3,603 shares for an estimated $1,012,037.
- JOEL UNRUCH (General Counsel/Corp Secretary) has made 0 purchases and 5 sales selling 2,358 shares for an estimated $655,324.
- RYOJI SEKIDO (Co-CEO Asia Pacific) has made 0 purchases and 3 sales selling 2,500 shares for an estimated $623,674.
- KATHERINE LEE CLIFFORD (Chief Leadership & HR Officer) has made 0 purchases and 13 sales selling 1,468 shares for an estimated $412,092.
- MAURO MACCHI (Chief Executive Officer-EMEA) has made 0 purchases and 2 sales selling 1,000 shares for an estimated $280,000.
- CATHERINE KIERNAN HOGAN (Chief Operating Officer) has made 0 purchases and 5 sales selling 660 shares for an estimated $185,412.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ACCENTURE Hedge Fund Activity
We have seen 994 institutional investors add shares of ACCENTURE stock to their portfolio, and 1,377 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 15,926,414 shares (-74.7%) from their portfolio in Q4 2025, for an estimated $4,273,056,876
- MORGAN STANLEY removed 4,496,538 shares (-37.4%) from their portfolio in Q4 2025, for an estimated $1,206,421,145
- FMR LLC added 2,480,421 shares (+68.5%) to their portfolio in Q4 2025, for an estimated $665,496,954
- UBS GROUP AG removed 1,689,536 shares (-38.7%) from their portfolio in Q4 2025, for an estimated $453,302,508
- PACER ADVISORS, INC. removed 1,527,643 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $409,866,616
- MITSUBISHI UFJ ASSET MANAGEMENT CO., LTD. removed 1,419,814 shares (-52.1%) from their portfolio in Q4 2025, for an estimated $380,936,096
- SANDERS CAPITAL, LLC added 1,348,249 shares (+14.0%) to their portfolio in Q4 2025, for an estimated $361,735,206
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ACCENTURE Government Contracts
We have seen $3,090,919,326 of award payments to $ACN over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- FEDERALLY FACILITATED EXCHANGE (FFE): $185,678,383
- VBA DGIB SUPPORT SERVICES PURCHASE: $184,223,078
- TITLE IV FINANCIAL AID ORIGINATION AND DISBURSEMENT (TIVOD) SYSTEMS AND CUSTOMER SERVICE TRANSITION SERVICES: $152,839,687
- THIS TASK ORDER IS FOR AN ENTERPRISE-WIDE DIGITAL AND CUSTOMER CARE PLATFORMS AND SERVICES SOLUTION (ENTERP...: $148,862,933
- SEE CONTRACT SCHEDULE, ATTACHMENTS, AND EXHIBITS.: $143,245,848
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
ACCENTURE Congressional Stock Trading
Members of Congress have traded $ACN stock 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $ACN stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 12/19 and 1 sale worth up to $15,000 on 02/10.
- REPRESENTATIVE KEVIN HERN has traded it 2 times. They made 0 purchases and 2 sales worth up to $300,000 on 10/27, 09/26.
- SENATOR MARKWAYNE MULLIN sold up to $50,000 on 09/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ACCENTURE Analyst Ratings
Wall Street analysts have issued reports on $ACN in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 12/19/2025
- UBS issued a "Buy" rating on 12/19/2025
- Mizuho issued a "Outperform" rating on 09/29/2025
- JP Morgan issued a "Overweight" rating on 09/26/2025
- Baird issued a "Outperform" rating on 09/26/2025
- Guggenheim issued a "Buy" rating on 09/26/2025
- Evercore ISI Group issued a "Outperform" rating on 09/26/2025
To track analyst ratings and price targets for ACCENTURE, check out Quiver Quantitative's $ACN forecast page.
ACCENTURE Price Targets
Multiple analysts have issued price targets for $ACN recently. We have seen 16 analysts offer price targets for $ACN in the last 6 months, with a median target of $278.5.
Here are some recent targets:
- Bryan C. Bergin from TD Cowen set a target price of $275.0 on 03/16/2026
- James Faucette from Morgan Stanley set a target price of $240.0 on 03/16/2026
- Jonathan Lee from Guggenheim set a target price of $275.0 on 03/11/2026
- Arvind Ramnani from Truist Securities set a target price of $260.0 on 03/10/2026
- Bryan Keane from Citigroup set a target price of $215.0 on 02/25/2026
- Jason Kupferberg from Wells Fargo set a target price of $275.0 on 02/17/2026
- James Friedman from Susquehanna set a target price of $277.0 on 12/19/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
